The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Facilitating meaningful patient involvement in the design and conduct of cancer research: The Breast International Group (BIG) patient partnership model.
 
Judy Needham
No Relationships to Disclose
 
Virginie Adam
Employment - Janssen (I)
Research Funding - AstraZeneca (Inst); GlaxoSmithKline/Tesaro (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
 
Carmela Caballero
Research Funding - AstraZeneca (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst); Sanofi (Inst)
Other Relationship - European Society of Surgical Oncology
 
Leslie Gilham
Consulting or Advisory Role - Roche/Genentech
Other Relationship - Breast Cancer Trials Australia and New Zealand; Breast International Group
 
Lydie Meheus
No Relationships to Disclose
 
Hilary Stobart
No Relationships to Disclose
 
Mairead MacKenzie
No Relationships to Disclose
 
Concepcion Biurrun
Honoraria - Federación Española de Cáncer de Mama - Cancer Patients Europe (Inst)
 
Ana Casas
No Relationships to Disclose
 
Lynda Belhadi
No Relationships to Disclose
 
Julia Maues
No Relationships to Disclose
 
Christine Hodgdon
Honoraria - Roche/Genentech
Consulting or Advisory Role - Cancer Moonshot; Johns Hopkins Hospital; Pfizer; Roche/Genentech; Seagen
Travel, Accommodations, Expenses - Lilly
 
Eva Schumacher-Wulf
No Relationships to Disclose
 
Tanja Španic
Honoraria - MSD Oncology; Pfizer; Roche
Consulting or Advisory Role - Roche
Expert Testimony - AstraZeneca
Travel, Accommodations, Expenses - MSD Oncology
Other Relationship - Roche
 
Orsolya Birta
Research Funding - AstraZeneca/UK (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Carolyn Straehle
Research Funding - AstraZeneca/UK (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst)
 
Judith Bliss
Research Funding - AstraZeneca (Inst); Clovis Oncology (Inst); GlaxoSmithKline/Novartis (Inst); Janssen-Cilag (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Pfizer
 
Boon Chua
Other Relationship - Veracyte (Inst); Veracyte (Inst)
 
David Cameron
Consulting or Advisory Role - AstraZeneca (Inst); Clarity Pharmaceuticals (Inst); Daiichi Sankyo (Inst); ERYTECH Pharma (Inst); Exact Sciences (Inst); Genentech/Roche (Inst); Grail (Inst); Lilly (Inst); Next Generation Healthcare communications (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche (Inst); Sanofi (Inst); Seagen (Inst); Synthon (Inst); Zymeworks (Inst)
Research Funding - AstraZeneca (Inst); Novartis (Inst); Roche (Inst)